Influenza Antiviral Prescribing for Outpatients With an Acute Respiratory Illness and at High Risk for Influenza-Associated Complications During 5 Influenza Seasons—United States, 2011–2016 | Zendy

Rebekah J. Stewart | Zendy; Brendan Flannery | Zendy; Jessie R. Chung | Zendy; Manjusha Gaglani | Zendy; Michael Reis | Zendy; Richard K. Zimmerman | Zendy; Mary Patricia Nowalk | Zendy; Lisa A. Jackson | Zendy; Michael L. Jackson | Zendy; Arnold S. Monto | Zendy; Emily T. Martin | Zendy; Edward A. Belongia | Zendy; Huong Q. McLean | Zendy; Alicia M. Fry | Zendy; Fiona P. Havers | Zendy

Open Access

Influenza Antiviral Prescribing for Outpatients With an Acute Respiratory Illness and at High Risk for Influenza-Associated Complications During 5 Influenza Seasons—United States, 2011–2016

Author(s) -

Rebekah J. Stewart,

Brendan Flannery,

Jessie R. Chung,

Manjusha Gaglani,

Michael Reis,

Richard K. Zimmerman,

Mary Patricia Nowalk,

Lisa A. Jackson,

Michael L. Jackson,

Arnold S. Monto,

Emily T. Martin,

Edward A. Belongia,

Huong Q. McLean,

Alicia M. Fry,

Fiona P. Havers

Publication year - 2017

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cix922

Subject(s) - medicine , odds ratio , confidence interval , influenza like illness , medical prescription , antiviral drug , medical record , intensive care medicine , pediatrics , emergency medicine , immunology , virus , pharmacology

Influenza causes millions of illnesses annually; certain groups are at higher risk for complications. Early antiviral treatment can reduce the risk of complications and is recommended for outpatients at increased risk. We describe antiviral prescribing among high-risk outpatients for 5 influenza seasons and explore factors that may influence prescribing.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research